CS-917
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CS-917, covering 2007-09-11 to 2007-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917 [Phase 2]